Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

NCT00741260 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Neratinib
DRUG: Capecitabine

Sponsor

Puma Biotechnology, Inc.